Explains What Happened
Analytics reveals historical patterns and trends. It helps explain the past - but not why complex systems behave as they do.
Transform complex systems into computable models that reveal hidden relationships, eliminate costly blind spots, and uncover new knowledge beyond the limits of traditional AI, and knowledge graphs.
The Gap
Traditional technologies help us analyze the past, predict likely outcomes, and organize existing knowledge. But complex problems emerge from hidden relationships, incomplete evidence, sparse data, and interacting dimensions that cannot be fully predefined.
Discovery requires making complexity computable.
Analytics reveals historical patterns and trends. It helps explain the past - but not why complex systems behave as they do.
AI recognizes patterns and predicts outcomes from large data sets. But prediction alone can’t model the interacting dimensions driving a complex system.
Knowledge graphs connect and represent existing knowledge. Their entities and relationships must be pre-encoded, validated, and maintained as complexity grows.
Discovery Intelligence models complex systems to reveal hidden relationships, evaluate competing theories, and uncover new knowledge.
Prediction tells you what is likely. Knowledge graphs organize what is known. Discovery Intelligence reveals what neither can tell you.
See How It Works →Discovery Intelligence
Discovery Intelligence is designed to make complexity computable - transforming interacting dimensions, incomplete or competing evidence, and hidden relationships into real-world models where new knowledge can emerge.
From Complex Problem to New Knowledge
A proven methodology for turning complexity into discovery.
The problem inquiry frames the discovery boundary - what you’re trying to understand, not what data you have.
Each dimension is modeled independently as its own expertise graph, built from its own structure, evidence, and context. Domain experts can embed rules and knowledge directly into the model.
Compose independent expertise graphs into a real-world model of the full multidimensional problem space.
The engine explores relationships across all dimensions of the model to surface what no one has predefined or encoded.
New relationships, insights, and discoveries emerge - ready to be acted upon and built into reusable knowledge.
Published Research
Our discovery methodology has been independently validated in peer-reviewed research across two disease areas - findings other pipelines could not surface, confirmed by an outside research team.
Our multidimensional analysis surfaced genetic associations in endometriosis that conventional genomic pipelines could not detect - associations that were independently validated by the research team.
Applied to lung cancer pathology, our AI scan metadata analysis model identified a concentration threshold linked to EGFR mutation status. Built on Moroccan and North African patient data, a population absent from the EGFR models built on European, Asian and American data. It’s an evidence-based approach: the model keeps the attributes that carry real signal and drops those that don’t, such as age and sex.
Applied to a complex healthcare program, the methodology surfaced specific individuals responsible for hundreds of thousands of dollars in fraudulent drug claims - a pattern invisible to every existing compliance and analytics system in the organization.
Applied to crisis decision-making in aviation operations - modeling resource constraints, operational uncertainty, and decision pathways under real-time pressure - the methodology surfaced actionable decision signals amid volatility and ambiguity that conventional planning tools could not produce.
The Discovery Ecosystem
Each module answers a domain-specific problem - the essential starting point for a market-ready solution. Built with partners and domain experts from validated discoveries: some public, some private, more on the way.
Surfaces clinically meaningful signal in variants of unknown significance - turning genomic ambiguity into interpretable, testable findings. Public and in use today.
Explore VUS Discovery ↗Developing the validated lung-cancer metadata model into a reusable discovery module that flags when EGFR molecular testing is warranted. Phase 2 validation underway.
Contact UsSurfaces non-obvious matches between existing drugs and new indications - repurposing candidates conventional screening misses because the signal lives across interacting biological dimensions no single model connects.
Contact UsSurfaces actionable decision signals under real-time uncertainty - resource constraints, volatility, and ambiguity conventional planning tools can’t model. Available to partners by request.
Contact UsFinds fraud living across interacting dimensions that single-system compliance and analytics tools miss. Deployed with partners under private engagement.
Contact UsEach solution begins with a focused inquiry and a starting model for a complex-system domain - built with a partner who knows the field.